about
Chagas disease: "the new HIV/AIDS of the Americas"Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyCourse of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up StudiesRole of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and diseaseTreatment of Chagas cardiomyopathyStem Cell-Based Therapies in Chagasic CardiomyopathyClinical and echocardiographic predictors of mortality in chagasic cardiomyopathy--systematic reviewAdipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite ImmunityBradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responsesStructure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas’ diseaseCrystal Structure of the Complex mAb 17.2 and the C-Terminal Region of Trypanosoma cruzi P2β Protein: Implications in Cross-ReactivityDifferential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineageBenznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of BrazilPathogenesis of chagas' disease: parasite persistence and autoimmunityMechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy[102 patients with suspected myocarditis : Clinical presentation, diagnostics, therapy and prognosis].Challenges and perspectives of Chagas disease: a review.Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.Causal inference regarding infectious aetiology of chronic conditions: a systematic review.The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination.Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia.Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.Hyperendemic Chagas disease and the unmet need for pacemakers in the Bolivian Chaco.Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart diseaseCardiac involvement with parasitic infections.Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathyArylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatmentSubdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.Effects of cholinergic stimulation with pyridostigmine bromide on chronic chagasic cardiomyopathic mice.Current and developing therapeutic agents in the treatment of Chagas diseaseStroke correlates in chagasic and non-chagasic cardiomyopathies.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.
P2860
Q21144502-762B37CE-DBAF-4A8C-896C-FF9DADE8BF18Q24202908-C2AD75CC-538E-43A7-9589-20BA3EFB0E96Q24235451-A52844F0-F529-4A6A-9A1E-50826D2A6C8BQ26471149-4B9E09D3-1302-4A60-A1C7-006393390C41Q26782118-31E4B4C7-D373-4756-ADD6-85FF3A69848BQ26828498-6184AE40-5C94-4A0B-9707-755B49902937Q26829616-9D0285EA-9D4B-485C-890F-2F843721E52BQ26852985-CDB16AB2-48C7-41EE-9F27-1285EC011960Q27002088-8190E566-5295-417E-BD9C-4F2CBFA7C373Q27304355-FEAACF03-164A-4FCC-AA09-F80510A5BD1AQ27319499-6E9714F6-AD42-49A6-9E8F-B2C08691CD02Q27675033-F51F5C2F-3FD9-4528-B107-1F047DAF9113Q27675467-D1A8D93B-B34D-4722-A25C-B7564D652BA6Q28481727-BF0957C9-861B-424C-89D0-12836869E181Q28553577-8989CE67-B2C7-4370-ABEF-07A866E0F2B2Q28742827-04A6D4C2-29A1-44E8-B884-B3F56E9E3E4EQ29248645-944C0839-0882-44EF-AA49-0D2912260714Q30313532-236D34A8-D97E-4004-A56C-50B5D6B9E8FDQ30566256-8C21C700-09CB-4EB7-8379-670936DA27FEQ30918385-88BA9DE6-A2F5-4771-BDC9-3F14A0119359Q31126057-6977F833-BDC3-4AFA-8030-16193F5A4E88Q33372349-5B8DCAD5-C0B3-4107-847C-590162236A1BQ33518515-EBC7B030-12EE-499F-AB93-F9341EB32110Q33587283-9AC084CA-93CB-4387-88AF-9EA19B833ABEQ33656471-554EC74B-1384-4D02-B327-59E267704096Q33716604-870CADA5-04C1-490B-9078-C50A5C9DCA12Q33773325-2028EA71-A833-47CC-B5FD-264F0FCD5B5BQ33825602-B58359F9-4724-44C0-9516-06F919876989Q33921202-4CFF700F-71E1-45F3-919E-A598CC4068FDQ33955413-EB7153F6-2503-44F8-8E81-7B4F2C3260A6Q33962768-1BEA2EEE-AF55-4028-A1DE-7E09685A932EQ33968196-4355955D-E146-4AB5-BEAB-A8A20C9E9471Q34023102-E9D2BAA9-B2F2-456A-9144-C72A75F24F8EQ34069688-54AF297E-773A-4657-A940-763064E50329Q34112124-7A4DFDD8-5D5C-4DD5-B1C1-A603B1464FCAQ34152059-06DCDB5B-22EF-4FD4-9F69-D03DD91DB07BQ34170132-F0BFD4F3-92C1-4460-ACEE-B56D53DA7EC7Q34241769-270135FD-3C77-4A5E-BA32-F93E1592AF47Q34250328-3D9AC421-8B51-445F-95F3-AE771267A5E5Q34277020-9ACE1051-9EEC-4146-B195-C3E7744E1753
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pathogenesis of chronic Chagas heart disease
@ast
Pathogenesis of chronic Chagas heart disease
@en
Pathogenesis of chronic Chagas heart disease
@nl
type
label
Pathogenesis of chronic Chagas heart disease
@ast
Pathogenesis of chronic Chagas heart disease
@en
Pathogenesis of chronic Chagas heart disease
@nl
prefLabel
Pathogenesis of chronic Chagas heart disease
@ast
Pathogenesis of chronic Chagas heart disease
@en
Pathogenesis of chronic Chagas heart disease
@nl
P2093
P3181
P1433
P1476
Pathogenesis of chronic Chagas heart disease
@en
P2093
Benedito C Maciel
Jose Antonio Marin-Neto
Marcus V Simões
P304
P3181
P356
10.1161/CIRCULATIONAHA.106.624296
P407
P5008
P577
2007-03-06T00:00:00Z